A	O
Head	O
-	O
to	O
-	O
Head	O
Comparison	O
of	O
UK	B:C0041700
SF	O
-	I:C3827843
6D	I:C3827843
and	O
Thai	O
and	O
UK	O
EQ	O
-	I:C3827843
5D	I:C3827843
-	I:C3827843
5L	I:C3827843
Value	I:C3827843
Sets	I:C3827843
in	O
Thai	O
Patients	O
with	O
Chronic	O
Diseases	I:C0008679
.	O

A	O
Head	O
-	O
to	O
-	O
Head	O
Comparison	O
of	O
UK	O
SF	B:C3827843
-	I:C3827843
6D	I:C3827843
and	O
Thai	O
and	O
UK	O
EQ	O
-	I:C3827843
5D	I:C3827843
-	I:C3827843
5L	I:C3827843
Value	I:C3827843
Sets	I:C3827843
in	O
Thai	O
Patients	O
with	O
Chronic	O
Diseases	I:C0008679
.	O

A	O
Head	O
-	O
to	O
-	O
Head	O
Comparison	O
of	O
UK	O
SF	O
-	I:C3827843
6D	I:C3827843
and	O
Thai	B:C0039725
and	O
UK	O
EQ	O
-	I:C3827843
5D	I:C3827843
-	I:C3827843
5L	I:C3827843
Value	I:C3827843
Sets	I:C3827843
in	O
Thai	O
Patients	O
with	O
Chronic	O
Diseases	I:C0008679
.	O

A	O
Head	O
-	O
to	O
-	O
Head	O
Comparison	O
of	O
UK	O
SF	O
-	I:C3827843
6D	I:C3827843
and	O
Thai	O
and	O
UK	B:C0041700
EQ	O
-	I:C3827843
5D	I:C3827843
-	I:C3827843
5L	I:C3827843
Value	I:C3827843
Sets	I:C3827843
in	O
Thai	O
Patients	O
with	O
Chronic	O
Diseases	I:C0008679
.	O

A	O
Head	O
-	O
to	O
-	O
Head	O
Comparison	O
of	O
UK	O
SF	O
-	I:C3827843
6D	I:C3827843
and	O
Thai	O
and	O
UK	O
EQ	B:C3827843
-	I:C3827843
5D	I:C3827843
-	I:C3827843
5L	I:C3827843
Value	I:C3827843
Sets	I:C3827843
in	O
Thai	O
Patients	O
with	O
Chronic	O
Diseases	I:C0008679
.	O

A	O
Head	O
-	O
to	O
-	O
Head	O
Comparison	O
of	O
UK	O
SF	O
-	I:C3827843
6D	I:C3827843
and	O
Thai	O
and	O
UK	O
EQ	O
-	I:C3827843
5D	I:C3827843
-	I:C3827843
5L	I:C3827843
Value	I:C3827843
Sets	I:C3827843
in	O
Thai	B:C0039725
Patients	O
with	O
Chronic	O
Diseases	I:C0008679
.	O

A	O
Head	O
-	O
to	O
-	O
Head	O
Comparison	O
of	O
UK	O
SF	O
-	I:C3827843
6D	I:C3827843
and	O
Thai	O
and	O
UK	O
EQ	O
-	I:C3827843
5D	I:C3827843
-	I:C3827843
5L	I:C3827843
Value	I:C3827843
Sets	I:C3827843
in	O
Thai	O
Patients	O
with	O
Chronic	B:C0008679
Diseases	I:C0008679
.	O

Little	O
was	O
known	O
about	O
the	O
head	O
-	O
to	O
-	O
head	O
comparison	O
of	O
psychometric	B:C0033920
properties	I:C0033920
between	O
SF	O
-	I:C3827843
6D	I:C3827843
and	O
EQ	O
-	I:C3827843
5D	I:C3827843
-	I:C3827843
5L	I:C3827843
or	O
the	O
different	O
value	O
sets	I:C3827843
of	O
EQ	O
-	I:C3827843
5D	I:C3827843
-	I:C3827843
5L	I:C3827843
.	O

Little	O
was	O
known	O
about	O
the	O
head	O
-	O
to	O
-	O
head	O
comparison	O
of	O
psychometric	O
properties	I:C0033920
between	O
SF	B:C3827843
-	I:C3827843
6D	I:C3827843
and	O
EQ	O
-	I:C3827843
5D	I:C3827843
-	I:C3827843
5L	I:C3827843
or	O
the	O
different	O
value	O
sets	I:C3827843
of	O
EQ	O
-	I:C3827843
5D	I:C3827843
-	I:C3827843
5L	I:C3827843
.	O

Little	O
was	O
known	O
about	O
the	O
head	O
-	O
to	O
-	O
head	O
comparison	O
of	O
psychometric	O
properties	I:C0033920
between	O
SF	O
-	I:C3827843
6D	I:C3827843
and	O
EQ	B:C3827843
-	I:C3827843
5D	I:C3827843
-	I:C3827843
5L	I:C3827843
or	O
the	O
different	O
value	O
sets	I:C3827843
of	O
EQ	O
-	I:C3827843
5D	I:C3827843
-	I:C3827843
5L	I:C3827843
.	O

Little	O
was	O
known	O
about	O
the	O
head	O
-	O
to	O
-	O
head	O
comparison	O
of	O
psychometric	O
properties	I:C0033920
between	O
SF	O
-	I:C3827843
6D	I:C3827843
and	O
EQ	O
-	I:C3827843
5D	I:C3827843
-	I:C3827843
5L	I:C3827843
or	O
the	O
different	O
value	B:C3827843
sets	I:C3827843
of	O
EQ	O
-	I:C3827843
5D	I:C3827843
-	I:C3827843
5L	I:C3827843
.	O

Little	O
was	O
known	O
about	O
the	O
head	O
-	O
to	O
-	O
head	O
comparison	O
of	O
psychometric	O
properties	I:C0033920
between	O
SF	O
-	I:C3827843
6D	I:C3827843
and	O
EQ	O
-	I:C3827843
5D	I:C3827843
-	I:C3827843
5L	I:C3827843
or	O
the	O
different	O
value	O
sets	I:C3827843
of	O
EQ	B:C3827843
-	I:C3827843
5D	I:C3827843
-	I:C3827843
5L	I:C3827843
.	O

Therefore	O
,	O
this	O
study	O
set	O
out	O
to	O
compare	O
the	O
psychometric	B:C0033920
properties	I:C0033920
including	O
agreement	O
,	O
convergent	O
,	O
and	O
known	O
-	O
group	O
validity	O
between	O
the	O
SF	O
-	I:C3827843
6D	I:C3827843
and	O
the	O
EQ	O
-	I:C3827843
5D	I:C3827843
-	I:C3827843
5L	I:C3827843
using	O
the	O
real	O
value	I:C3827843
sets	I:C3827843
from	O
Thailand	O
and	O
the	O
UK	O
in	O
patients	O
with	O
chronic	O
diseases	I:C0008679
.	O

Therefore	O
,	O
this	O
study	O
set	O
out	O
to	O
compare	O
the	O
psychometric	O
properties	I:C0033920
including	O
agreement	O
,	O
convergent	O
,	O
and	O
known	O
-	O
group	O
validity	O
between	O
the	O
SF	B:C3827843
-	I:C3827843
6D	I:C3827843
and	O
the	O
EQ	O
-	I:C3827843
5D	I:C3827843
-	I:C3827843
5L	I:C3827843
using	O
the	O
real	O
value	I:C3827843
sets	I:C3827843
from	O
Thailand	O
and	O
the	O
UK	O
in	O
patients	O
with	O
chronic	O
diseases	I:C0008679
.	O

Therefore	O
,	O
this	O
study	O
set	O
out	O
to	O
compare	O
the	O
psychometric	O
properties	I:C0033920
including	O
agreement	O
,	O
convergent	O
,	O
and	O
known	O
-	O
group	O
validity	O
between	O
the	O
SF	O
-	I:C3827843
6D	I:C3827843
and	O
the	O
EQ	B:C3827843
-	I:C3827843
5D	I:C3827843
-	I:C3827843
5L	I:C3827843
using	O
the	O
real	O
value	I:C3827843
sets	I:C3827843
from	O
Thailand	O
and	O
the	O
UK	O
in	O
patients	O
with	O
chronic	O
diseases	I:C0008679
.	O

Therefore	O
,	O
this	O
study	O
set	O
out	O
to	O
compare	O
the	O
psychometric	O
properties	I:C0033920
including	O
agreement	O
,	O
convergent	O
,	O
and	O
known	O
-	O
group	O
validity	O
between	O
the	O
SF	O
-	I:C3827843
6D	I:C3827843
and	O
the	O
EQ	O
-	I:C3827843
5D	I:C3827843
-	I:C3827843
5L	I:C3827843
using	O
the	O
real	B:C3827843
value	I:C3827843
sets	I:C3827843
from	O
Thailand	O
and	O
the	O
UK	O
in	O
patients	O
with	O
chronic	O
diseases	I:C0008679
.	O

Therefore	O
,	O
this	O
study	O
set	O
out	O
to	O
compare	O
the	O
psychometric	O
properties	I:C0033920
including	O
agreement	O
,	O
convergent	O
,	O
and	O
known	O
-	O
group	O
validity	O
between	O
the	O
SF	O
-	I:C3827843
6D	I:C3827843
and	O
the	O
EQ	O
-	I:C3827843
5D	I:C3827843
-	I:C3827843
5L	I:C3827843
using	O
the	O
real	O
value	I:C3827843
sets	I:C3827843
from	O
Thailand	B:C0039725
and	O
the	O
UK	O
in	O
patients	O
with	O
chronic	O
diseases	I:C0008679
.	O

Therefore	O
,	O
this	O
study	O
set	O
out	O
to	O
compare	O
the	O
psychometric	O
properties	I:C0033920
including	O
agreement	O
,	O
convergent	O
,	O
and	O
known	O
-	O
group	O
validity	O
between	O
the	O
SF	O
-	I:C3827843
6D	I:C3827843
and	O
the	O
EQ	O
-	I:C3827843
5D	I:C3827843
-	I:C3827843
5L	I:C3827843
using	O
the	O
real	O
value	I:C3827843
sets	I:C3827843
from	O
Thailand	O
and	O
the	O
UK	B:C0041700
in	O
patients	O
with	O
chronic	O
diseases	I:C0008679
.	O

Therefore	O
,	O
this	O
study	O
set	O
out	O
to	O
compare	O
the	O
psychometric	O
properties	I:C0033920
including	O
agreement	O
,	O
convergent	O
,	O
and	O
known	O
-	O
group	O
validity	O
between	O
the	O
SF	O
-	I:C3827843
6D	I:C3827843
and	O
the	O
EQ	O
-	I:C3827843
5D	I:C3827843
-	I:C3827843
5L	I:C3827843
using	O
the	O
real	O
value	I:C3827843
sets	I:C3827843
from	O
Thailand	O
and	O
the	O
UK	O
in	O
patients	O
with	O
chronic	B:C0008679
diseases	I:C0008679
.	O

356	O
adults	O
taking	O
a	O
medication	B:C0013227
for	O
at	O
least	O
3	O
months	O
were	O
identified	O
from	O
a	O
university	O
hospital	I:C0020028
in	O
Bangkok	O
,	I:C0039725
Thailand	I:C0039725
,	O
between	O
July	O
2014	O
and	O
March	O
2015	O
.	O

356	O
adults	O
taking	O
a	O
medication	O
for	O
at	O
least	O
3	O
months	O
were	O
identified	O
from	O
a	O
university	B:C0020028
hospital	I:C0020028
in	O
Bangkok	O
,	I:C0039725
Thailand	I:C0039725
,	O
between	O
July	O
2014	O
and	O
March	O
2015	O
.	O

356	O
adults	O
taking	O
a	O
medication	O
for	O
at	O
least	O
3	O
months	O
were	O
identified	O
from	O
a	O
university	O
hospital	I:C0020028
in	O
Bangkok	B:C0039725
,	I:C0039725
Thailand	I:C0039725
,	O
between	O
July	O
2014	O
and	O
March	O
2015	O
.	O

Convergent	O
validity	O
was	O
evaluated	B:C0220825
using	O
Spearman	O
's	O
rank	O
correlation	O
coefficients	O
between	O
SF	O
-	I:C3827843
6D	I:C3827843
and	O
EQ	O
-	I:C3827843
5D	I:C3827843
-	I:C3827843
5L	I:C3827843
and	O
EQ	O
-	I:C3827843
VAS	I:C3827843
and	O
SF	O
-	I:C3827843
12v2	I:C3827843
.	O

Convergent	O
validity	O
was	O
evaluated	O
using	O
Spearman	O
's	O
rank	O
correlation	O
coefficients	O
between	O
SF	B:C3827843
-	I:C3827843
6D	I:C3827843
and	O
EQ	O
-	I:C3827843
5D	I:C3827843
-	I:C3827843
5L	I:C3827843
and	O
EQ	O
-	I:C3827843
VAS	I:C3827843
and	O
SF	O
-	I:C3827843
12v2	I:C3827843
.	O

Convergent	O
validity	O
was	O
evaluated	O
using	O
Spearman	O
's	O
rank	O
correlation	O
coefficients	O
between	O
SF	O
-	I:C3827843
6D	I:C3827843
and	O
EQ	B:C3827843
-	I:C3827843
5D	I:C3827843
-	I:C3827843
5L	I:C3827843
and	O
EQ	O
-	I:C3827843
VAS	I:C3827843
and	O
SF	O
-	I:C3827843
12v2	I:C3827843
.	O

Convergent	O
validity	O
was	O
evaluated	O
using	O
Spearman	O
's	O
rank	O
correlation	O
coefficients	O
between	O
SF	O
-	I:C3827843
6D	I:C3827843
and	O
EQ	O
-	I:C3827843
5D	I:C3827843
-	I:C3827843
5L	I:C3827843
and	O
EQ	B:C3827843
-	I:C3827843
VAS	I:C3827843
and	O
SF	O
-	I:C3827843
12v2	I:C3827843
.	O

Convergent	O
validity	O
was	O
evaluated	O
using	O
Spearman	O
's	O
rank	O
correlation	O
coefficients	O
between	O
SF	O
-	I:C3827843
6D	I:C3827843
and	O
EQ	O
-	I:C3827843
5D	I:C3827843
-	I:C3827843
5L	I:C3827843
and	O
EQ	O
-	I:C3827843
VAS	I:C3827843
and	O
SF	B:C3827843
-	I:C3827843
12v2	I:C3827843
.	O

For	O
known	O
-	O
groups	O
validity	O
,	O
the	O
Mann	O
-	O
Whitney	O
U	O
test	O
and	O
Kruskal	B:C1708614
-	I:C1708614
Wallis	I:C1708614
test	I:C1708614
were	O
used	O
to	O
examine	O
the	O
associations	O
between	O
SF	O
-	I:C3827843
6D	I:C3827843
and	O
EQ	O
-	I:C3827843
5D	I:C3827843
-	I:C3827843
5L	I:C3827843
and	O
patient	O
characteristics	O
.	O

For	O
known	O
-	O
groups	O
validity	O
,	O
the	O
Mann	O
-	O
Whitney	O
U	O
test	O
and	O
Kruskal	O
-	I:C1708614
Wallis	I:C1708614
test	I:C1708614
were	O
used	O
to	O
examine	O
the	O
associations	O
between	O
SF	B:C3827843
-	I:C3827843
6D	I:C3827843
and	O
EQ	O
-	I:C3827843
5D	I:C3827843
-	I:C3827843
5L	I:C3827843
and	O
patient	O
characteristics	O
.	O

For	O
known	O
-	O
groups	O
validity	O
,	O
the	O
Mann	O
-	O
Whitney	O
U	O
test	O
and	O
Kruskal	O
-	I:C1708614
Wallis	I:C1708614
test	I:C1708614
were	O
used	O
to	O
examine	O
the	O
associations	O
between	O
SF	O
-	I:C3827843
6D	I:C3827843
and	O
EQ	B:C3827843
-	I:C3827843
5D	I:C3827843
-	I:C3827843
5L	I:C3827843
and	O
patient	O
characteristics	O
.	O

Agreement	O
s	O
between	O
the	O
SF	B:C3827843
-	I:C3827843
6D	I:C3827843
and	O
the	O
EQ	O
-	I:C3827843
5D	I:C3827843
-	I:C3827843
5L	I:C3827843
using	O
Thai	O
and	O
UK	O
value	O
sets	I:C3827843
were	O
fair	O
,	O
with	O
ICCs	O
of	O
0.45	O
and	O
0.49	O
,	O
respectively	O
.	O

Agreement	O
s	O
between	O
the	O
SF	O
-	I:C3827843
6D	I:C3827843
and	O
the	O
EQ	B:C3827843
-	I:C3827843
5D	I:C3827843
-	I:C3827843
5L	I:C3827843
using	O
Thai	O
and	O
UK	O
value	O
sets	I:C3827843
were	O
fair	O
,	O
with	O
ICCs	O
of	O
0.45	O
and	O
0.49	O
,	O
respectively	O
.	O

Agreement	O
s	O
between	O
the	O
SF	O
-	I:C3827843
6D	I:C3827843
and	O
the	O
EQ	O
-	I:C3827843
5D	I:C3827843
-	I:C3827843
5L	I:C3827843
using	O
Thai	B:C0039725
and	O
UK	O
value	O
sets	I:C3827843
were	O
fair	O
,	O
with	O
ICCs	O
of	O
0.45	O
and	O
0.49	O
,	O
respectively	O
.	O

Agreement	O
s	O
between	O
the	O
SF	O
-	I:C3827843
6D	I:C3827843
and	O
the	O
EQ	O
-	I:C3827843
5D	I:C3827843
-	I:C3827843
5L	I:C3827843
using	O
Thai	O
and	O
UK	B:C0041700
value	O
sets	I:C3827843
were	O
fair	O
,	O
with	O
ICCs	O
of	O
0.45	O
and	O
0.49	O
,	O
respectively	O
.	O

Agreement	O
s	O
between	O
the	O
SF	O
-	I:C3827843
6D	I:C3827843
and	O
the	O
EQ	O
-	I:C3827843
5D	I:C3827843
-	I:C3827843
5L	I:C3827843
using	O
Thai	O
and	O
UK	O
value	B:C3827843
sets	I:C3827843
were	O
fair	O
,	O
with	O
ICCs	O
of	O
0.45	O
and	O
0.49	O
,	O
respectively	O
.	O

Bland	O
-	O
Altman	O
plots	O
showed	O
that	O
the	O
majority	O
of	O
the	O
SF	B:C3827843
-	I:C3827843
6D	I:C3827843
index	O
scores	I:C0918012
were	O
lower	O
than	O
the	O
EQ	O
-	I:C3827843
5D	I:C3827843
-	I:C3827843
5L	I:C3827843
index	O
scores	I:C0918012
.	O

Bland	O
-	O
Altman	O
plots	O
showed	O
that	O
the	O
majority	O
of	O
the	O
SF	O
-	I:C3827843
6D	I:C3827843
index	B:C0918012
scores	I:C0918012
were	O
lower	O
than	O
the	O
EQ	O
-	I:C3827843
5D	I:C3827843
-	I:C3827843
5L	I:C3827843
index	O
scores	I:C0918012
.	O

Bland	O
-	O
Altman	O
plots	O
showed	O
that	O
the	O
majority	O
of	O
the	O
SF	O
-	I:C3827843
6D	I:C3827843
index	O
scores	I:C0918012
were	O
lower	O
than	O
the	O
EQ	B:C3827843
-	I:C3827843
5D	I:C3827843
-	I:C3827843
5L	I:C3827843
index	O
scores	I:C0918012
.	O

Bland	O
-	O
Altman	O
plots	O
showed	O
that	O
the	O
majority	O
of	O
the	O
SF	O
-	I:C3827843
6D	I:C3827843
index	O
scores	I:C0918012
were	O
lower	O
than	O
the	O
EQ	O
-	I:C3827843
5D	I:C3827843
-	I:C3827843
5L	I:C3827843
index	B:C0918012
scores	I:C0918012
.	O

Both	O
the	O
EQ	B:C3827843
-	I:C3827843
5D	I:C3827843
-	I:C3827843
5L	I:C3827843
value	I:C3827843
sets	I:C3827843
were	O
more	O
related	O
to	O
the	O
EQ	O
-	I:C3827843
VAS	I:C3827843
and	O
physical	O
health	I:C0517226
,	O
while	O
the	O
SF	O
-	I:C3827843
6D	I:C3827843
was	O
more	O
associated	O
with	O
mental	O
health	I:C0025353
.	O

Both	O
the	O
EQ	O
-	I:C3827843
5D	I:C3827843
-	I:C3827843
5L	I:C3827843
value	I:C3827843
sets	I:C3827843
were	O
more	O
related	O
to	O
the	O
EQ	B:C3827843
-	I:C3827843
VAS	I:C3827843
and	O
physical	O
health	I:C0517226
,	O
while	O
the	O
SF	O
-	I:C3827843
6D	I:C3827843
was	O
more	O
associated	O
with	O
mental	O
health	I:C0025353
.	O

Both	O
the	O
EQ	O
-	I:C3827843
5D	I:C3827843
-	I:C3827843
5L	I:C3827843
value	I:C3827843
sets	I:C3827843
were	O
more	O
related	O
to	O
the	O
EQ	O
-	I:C3827843
VAS	I:C3827843
and	O
physical	B:C0517226
health	I:C0517226
,	O
while	O
the	O
SF	O
-	I:C3827843
6D	I:C3827843
was	O
more	O
associated	O
with	O
mental	O
health	I:C0025353
.	O

Both	O
the	O
EQ	O
-	I:C3827843
5D	I:C3827843
-	I:C3827843
5L	I:C3827843
value	I:C3827843
sets	I:C3827843
were	O
more	O
related	O
to	O
the	O
EQ	O
-	I:C3827843
VAS	I:C3827843
and	O
physical	O
health	I:C0517226
,	O
while	O
the	O
SF	B:C3827843
-	I:C3827843
6D	I:C3827843
was	O
more	O
associated	O
with	O
mental	O
health	I:C0025353
.	O

Both	O
the	O
EQ	O
-	I:C3827843
5D	I:C3827843
-	I:C3827843
5L	I:C3827843
value	I:C3827843
sets	I:C3827843
were	O
more	O
related	O
to	O
the	O
EQ	O
-	I:C3827843
VAS	I:C3827843
and	O
physical	O
health	I:C0517226
,	O
while	O
the	O
SF	O
-	I:C3827843
6D	I:C3827843
was	O
more	O
associated	O
with	O
mental	B:C0025353
health	I:C0025353
.	O

Both	O
EQ	B:C3827843
-	I:C3827843
5D	I:C3827843
-	I:C3827843
5L	I:C3827843
value	I:C3827843
sets	I:C3827843
were	O
more	O
sensitive	O
than	O
the	O
SF	O
-	I:C3827843
6D	I:C3827843
in	O
discriminating	O
patients	O
with	O
different	O
levels	O
of	O
more	O
known	O
groups	O
except	O
for	O
adverse	O
drug	I:C0041755
reactions	I:C0041755
.	O

Both	O
EQ	O
-	I:C3827843
5D	I:C3827843
-	I:C3827843
5L	I:C3827843
value	I:C3827843
sets	I:C3827843
were	O
more	O
sensitive	O
than	O
the	O
SF	B:C3827843
-	I:C3827843
6D	I:C3827843
in	O
discriminating	O
patients	O
with	O
different	O
levels	O
of	O
more	O
known	O
groups	O
except	O
for	O
adverse	O
drug	I:C0041755
reactions	I:C0041755
.	O

Both	O
EQ	O
-	I:C3827843
5D	I:C3827843
-	I:C3827843
5L	I:C3827843
value	I:C3827843
sets	I:C3827843
were	O
more	O
sensitive	O
than	O
the	O
SF	O
-	I:C3827843
6D	I:C3827843
in	O
discriminating	O
patients	O
with	O
different	O
levels	O
of	O
more	O
known	O
groups	O
except	O
for	O
adverse	B:C0041755
drug	I:C0041755
reactions	I:C0041755
.	O

The	O
SF	B:C3827843
-	I:C3827843
6D	I:C3827843
and	O
both	O
EQ	O
-	I:C3827843
5D	I:C3827843
-	I:C3827843
5L	I:C3827843
value	I:C3827843
sets	I:C3827843
appeared	O
to	O
be	O
valid	O
but	O
sensitive	O
to	O
different	O
outcomes	O
in	O
Thai	O
patients	O
with	O
chronic	O
diseases	I:C0008679
.	O

The	O
SF	O
-	I:C3827843
6D	I:C3827843
and	O
both	O
EQ	B:C3827843
-	I:C3827843
5D	I:C3827843
-	I:C3827843
5L	I:C3827843
value	I:C3827843
sets	I:C3827843
appeared	O
to	O
be	O
valid	O
but	O
sensitive	O
to	O
different	O
outcomes	O
in	O
Thai	O
patients	O
with	O
chronic	O
diseases	I:C0008679
.	O

The	O
SF	O
-	I:C3827843
6D	I:C3827843
and	O
both	O
EQ	O
-	I:C3827843
5D	I:C3827843
-	I:C3827843
5L	I:C3827843
value	I:C3827843
sets	I:C3827843
appeared	O
to	O
be	O
valid	O
but	O
sensitive	O
to	O
different	O
outcomes	O
in	O
Thai	B:C0039725
patients	O
with	O
chronic	O
diseases	I:C0008679
.	O

The	O
SF	O
-	I:C3827843
6D	I:C3827843
and	O
both	O
EQ	O
-	I:C3827843
5D	I:C3827843
-	I:C3827843
5L	I:C3827843
value	I:C3827843
sets	I:C3827843
appeared	O
to	O
be	O
valid	O
but	O
sensitive	O
to	O
different	O
outcomes	O
in	O
Thai	O
patients	O
with	O
chronic	B:C0008679
diseases	I:C0008679
.	O

